-
Mashup Score: 0
Each JACC Patient Care Pathway is an immersive, multimedia case report depicting the integration of cross-specialty decision making supported by evidence-based medicine within a single patient journey.
Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
Mazdutide dosed up to 9 mg and 10 mg was both well tolerated and showed a favourable safety profile. High-dose mazdutide showed promising 12-week body weight loss, holding great potential for the treatment of moderate-to-severe obesity. A larger and longer phase 2 trial will further evaluate the efficacy and safety of high-dose mazdutide in Chinese adults with obesity.
Source: EClinicalMedicineCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
📰New RCT: Safety and efficacy of a GLP-1 and IBI362 in Chinese adults with #overweight or #obesity Results suggested that mazdutide was well tolerated and showed a favourable safety profile. High-dose mazdutide showed promising 12-week body #weightloss https://t.co/ZPIsSw3LbE https://t.co/WW18antZB8
-
-
Mashup Score: 0Change in depressive symptoms may predict change in BMI - 2 year(s) ago
SAN DIEGO — For individuals, a change in depressive symptoms was associated with change in body weight, and the association was stronger for those with overweight or obesity than those with a normal BMI, according to study data. “Our findings show that it is important to compare people to their own usual depressive symptom levels, rather than comparing them to other people,”
Source: www.healio.comCategories: Endocrinology, Latest HeadlinesTweet-
Presented at #OW2022: Individuals with #overweight or #obesity are at higher risk for higher-than-usual #depressive symptoms compared with individuals with a normal BMI. @ObesityWeek @Julia_Namanka @MRC_Epid https://t.co/CfDjJzNkKt
-
-
Mashup Score: 2Sleep-deprived kids will snack more: Study - 2 year(s) ago
Experts studying kids’ sleep and eating habits have learned more about a potential reason for childhood obesity.
Source: medicalxpress.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
Sleep-deprived kids will snack more: Study #obesity #overweight #weight https://t.co/YicvLVGGPg
-
-
Mashup Score: 8Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial - Nature Medicine - 2 year(s) ago
Results from the STEP 5 trial, testing semaglutide as an adjunct to behavioral interventions in adults with overweight or obesity, demonstrate sustained weight loss over a period of 104 weeks.
Source: NatureCategories: Healthcare Professionals, Latest HeadlinesTweet-
Two-year effects of #semaglutide in adults with #overweight or #obesity: The mean change in body weight from baseline to week 104 was −15.2% in the semaglutide group (n = 152) versus −2.6% with placebo (n = 152), treatment difference of −12.6 % https://t.co/eI0m2zvP8m
-
-
Mashup Score: 2Economic impacts of overweight and obesity: current and future estimates for 161 countries - 2 year(s) ago
Introduction The scope of the challenge of overweight and obesity (OAO) has not been fully realised globally, in part because much of what is known about the economic impacts of OAO come from high-income countries (HICs) and are not readily comparable due to methodological differences. Our objective is to estimate the current and future national economic impacts of OAO globally. Methods We…
Source: BMJ Global HealthCategories: Healthcare Professionals, Latest HeadlinesTweet-
RT @adipofat: ▶️ Economic impacts of #overweight and #obesity: current and future estimates for 161 countries https://t.co/Rf19klJ9HV ▶️ Th…
-
-
Mashup Score: 0Weight Loss Outcomes and Semaglutide Treatment for Patients With Overweight or Obesity - 2 year(s) ago
This cohort study assesses weight loss outcomes of semaglutide at doses used in randomized clinical trials for patients with overweight or obesity.
Source: jamanetwork.comCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
Patients taking semaglutide achieved 6% and 11% of weight loss percentages at 3 and 6 months, respectively, supporting semaglutide’s applicability for #weightloss in patients with #overweight or #obesity. https://t.co/00fa6q6h8S #Research
-
-
Mashup Score: 1
Background Adolescent obesity has been reported to have deleterious consequences but is considered a promising modifiable risk factor. We aimed to investigate the optimal intervention for obese and overweight children and adolescents. Methods We searched the Medline (PubMed, 1946–December 2020), PsycINFO (Ovid, 1927–December 2020), Cochrane library (1966–December 2020), Web of Science…
Source: BioMed CentralCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
New research published in #BMCMedicine - https://t.co/SAsbe7IKoq Face-to-face #PhysicalActivity incorporated into #DietaryIntervention for #overweight in #adolescents: a #Bayesian network #MetaAnalysis Effective strategies to combat #obesity in #children https://t.co/kDXHDawOVq
-
-
Mashup Score: 1The avoidable disease burden associated with overweight and obesity in Kenya: A modelling study - 2 year(s) ago
The magnitude of avoidable high BMI-related disease burden in Kenya underscores the need to prioritise the control and prevention of overweight and obesity globally, especially in low- and middle-income settings, where obesity rates are rising rapidly. Reducing population BMI is challenging, but sustained and well-enforced system-wide approaches could be a great starting point.
Source: EClinicalMedicineCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
📰New modelling study: Avoidable disease burden associated with #overweight and #obesity in #Kenya The magnitude of high BMI-related disease burden underscores the need to prioritise prevention of overweight and obesity globally, especially in LMICs https://t.co/f36db0iU4M https://t.co/HQ2xTK2x5t
-
-
Mashup Score: 1Association between metabolic overweight/obesity phenotypes and readmission risk in patients with lung cancer: A retrospective cohort study - 2 year(s) ago
Increased BMI and metabolic abnormalities are independently associated with higher readmission risks in patients with lung cancer, whereas increased BMI also increases the readmission costs. Follow-up and intervention method targeting increased BMI and metabolic abnormalities should be considered for patients with lung cancer.
Source: EClinicalMedicineCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
🗞️New cohort study: Association between metabolic #overweight/ #obesity phenotypes and readmission risk in patients with lung cancer Data suggest that higher BMI and metabolic abnormalities are associated with greater risk of readmission in lung cancer https://t.co/x6oX8yR4Vq
-
.#Guidelines: Just published: addendum to 2019 ACC/AHA guideline on the Primary #Prevention of #Cardiovascular Disease. It clarifies the definition of processed meat. #RedMeat #Transfats #overweight #obesity; lean animal #protein. Read: https://t.co/BnHIpxzsDn https://t.co/UuezfZmNcU